Atavistik Bio
- Business Model
- B2B
- Website
- atavistikbio.com
- Total Funding
- $225.3M
- Last Round
- $40.0M Extension RoundMar 2026
- Rounds
- 4
About
Biotech company discovering transformative allosteric precision therapeutics for rare hematological disorders and cancers.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Mar 2026
Dec 2025
Dec 2025
Jan 2024
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...